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Human intestine 407 cells respond to hypo-osmotic stress by the
rapid release of ATP into the extracellular medium. A difference
in the time course of activation as well as in the sensitivity to
cytochalasin B treatment and BAPTA-AM [1,2-bis-(2-amino-
phenoxy)ethane-N,N,N«,N«-tetra-acetic acid acetoxymethyl ester]
loading suggests that ATP leaves the cell through a pathway
distinct from volume-regulated anion channels. To evaluate a
putative role for nucleotides as autocrinic}paracrinic factors in
osmotic signalling, the effects of extracellular ATP on the reg-
ulation of volume-sensitive anion channels as well as on the
hypotonicity-induced activation of extracellular signal-regulated
protein kinases (Erk-1}2) were investigated. Micromolar con-
centrations of ATP were unable to elicit an isotope efflux from
"#&I−-loaded cells by itself, but strongly potentiated the hypo-
tonicity-provoked anion efflux through a Ca#+-dependent mech-
anism. The order of potency of nucleotides (ATPflUTPfl
ATP[S]"ADPflAMP( adenosinefl cAMP) indicated the
involvement of P2Y
#
receptors. In contrast, millimolar concen-
trations of ATP markedly inhibited both the osmotically induced
isotope efflux and whole-cell Cl− currents. Inhibition of whole-
INTRODUCTION
Most cell types studied to date respond to alterations in cell
volume by evoking specific compensatory mechanisms. In gen-
eral, osmotic cell swelling leads to the activation of K+- and Cl−-
selective ionic channels and, depending on cell type and ex-
perimental conditions, to an accompanying efflux of organic
osmolytes (amino acids, polyols and methylamines; reviewed in
[1]). Although the mechanism of activation of the volume-
sensitive Cl− channels is as yet elusive, protein tyrosine phos-
phorylation was found to be critically involved in multiple cell
types [2–6]. Furthermore, activation of the ras-related G-protein
p21Rho appeared to be a prerequisite for activation of the volume-
regulated Cl− channels in bovine endothelial cells and human
intestine 407 cells [6,7]. Hypo-osmotic cell swelling is accom-
panied by a rapid phosphorylation and}or activation of a number
of other signalling enzymes, including members of the MAP
kinase (mitogen-activated protein kinase) family [2,8–14]. Ac-
tivation of MAP kinases, however, was not mandatory for the
regulation of osmo-sensitive Cl− channels [13,14]. Although the
molecular identity of the Cl− channels involved in cellular volume
regulation is not yet clear, the bioelectrical properties of osmo-
sensitive Cl− currents have been studied in many cell types. These
currents are characterized by a marked outward rectification, a
Abbreviations used: MAP kinase, mitogen-activated protein kinase ; MBP, myelin basic protein ; MTT, 3-(4,5-dimethylthiazolyl-2)-2,5-diphenylte-
trazolium bromide ; BAPTA-AM, 1,2-bis-(2-aminophenoxy)ethane-N,N,N«,N«-tetra-acetic acid acetoxymethyl ester ; Erk, extracellular signal-regulated
protein kinase.
1 To whom correspondence should be addressed.
cell Cl− currents, not only by millimolar ATP but also by the
purinoceptor antagonists suramin and reactive blue, was ob-
served most prominently at depolarizing holding potentials,
suggesting a direct interaction with volume-sensitive Cl− channels
rather than interaction with purinoceptors. Both ATP and UTP,
at submicromolar levels, were found to act as potent activators
of Erk-1}2 in intestine 407 cells. Addition of the ATP hydrolase
apyrase to the bath greatly reduced the hypotonicity-induced
Erk-1}2 activation, but did not affect the swelling-induced isotope
efflux or whole-cell Cl− currents. Furthermore, pre-treatment
with suramin or reactive blue almost completely prevented the
hypo-osmotic activation of Erk-1}2. The results indicate that
extracellularly released ATP functions as an autocrinic}para-
crinic factor that mediates hypotonicity-induced Erk-1}2 ac-
tivation but does not serve as an activator of volume-sensitive
compensatory Cl− currents.
Key words: chloride channels, mitogen-activated protein kinases,
regulatory volume decrease.
strong inactivation at positive holding potentials and an in-
hibition by extracellularly applied nucleotides (reviewed in
[15,16]).
Recent evidence indicates that ATP is released rapidly from
cells in response to increases in cellular cAMP, mechanical stress
or osmotic cell swelling [17–19]. Furthermore, extracellular ATP
has been recognized as an autocrinic factor involved in increasing
transmembrane Cl− permeabilities and in the activation of
volume-sensitive Cl− channels [17,18,20]. Binding of ATP to a
specific subclass of G-protein-coupled purinoceptors (the P2Y
subtypes) not only leads to phospholipase C-mediated activation
of protein kinase C and mobilization of Ca#+, but additionally
results in the activation of MAP kinases, including the extra-
cellular signal-regulated protein kinases (Erk-1}2) [21–27] and
the stress-activated protein kinase SAPK}JNK [28,29].
In this study, we used the human fetal jejunum-derived
intestine 407 cell line as a model to investigate the role of
extracellularly released ATP in the regulation of volume-sensitive
Cl− channels as well as its putative involvement in the activation
of Erk-1}2 by hypotonicity. Hypo-osmotic cell swelling was
found to result in a dose- and time-dependent release of ATP
into the medium, through a mechanism independent of the
activation of volume-sensitive Cl− channels. Furthermore, in
contrast with previous observations in other cell models
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[18,30,31], autocrinic}paracrinic ATP signalling did not serve as
a trigger to activate volume-sensitiveCl− channels.ATP signalling
through P2Y receptors, however, was found to be fully re-
sponsible for the hypo-osmotic activation of Erk-1}2.
MATERIALS AND METHODS
Materials
Radioisotopes ("#&I−, %&Ca#+ and [c-$#P]ATP) and enhanced
chemiluminescence (ECL) kit were purchased from Amersham
Netherlands B. V. (’s Hertogenbosch, The Netherlands). Poly-
clonal anti-Erk antibody was obtained from Santa Cruz Biot-
echnology (Santa Cruz, CA, U.S.A.). The Ca#+-ionophore
A23187 and cytotoxicity detection kit (lactate dehydrogenase)
were from Boehringer Mannheim (Mannheim, Germany), and
MTT [3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium
bromide], Protein A–Sepharose and luciferin}luciferase reagent
were obtained from Janssen Chimica (Geel, Belgium), Pharmacia
Biotech (Uppsala, Sweden) and Promega (Madison, WI, U.S.A.)
respectively. Other chemicals were purchased from Sigma (St.
Louis, MO, U.S.A.).
Cell culture
Intestine 407 cells were grown routinely as monolayers in
Dulbecco’s modified Eagle’s medium supplemented with 25 mM
Hepes, 10% fetal calf serum, 1% non-essential amino acids,
40 mg}l penicillin and 90 mg}l streptomycin under a humidified
atmosphere of 95% O
#
}5% CO
#
at 37 °C. Prior to the experi-
ments, cells were serum-starved overnight. Cell viability was
assessed by determining lactate dehydrogenase leakage according
to the instructions provided by the manufacturer (Boehringer
Mannheim) and by quantifying MTT conversion, as described
by Hansen et al. [32].
Efflux assays
Confluent monolayers of intestine 407 cells were loaded with
5 lCi}ml "#&I− or 0.5 lCi %&Ca#+ for 2 h in modified Meyler
solution (108 mM NaCl, 4.7 mM KCl, 1.3 mM CaCl
#
, 1 mM
MgCl
#
, 20 mM NaHCO
$
, 0.8 mM Na
#
HPO
%
, 0.4 mM NaH
#
PO
%
,
20 mM Hepes and 10 mM glucose, pH 7.4) under a 95% O
#
}5%
CO
#
humidified atmosphere. Subsequently, the cultures were
washed three times with isotonic buffer (80 mM NaCl, 4.7 mM
KCl, 1.3 mM CaCl
#
, 1 mM MgCl
#
, 10 mM glucose, 95 mM
mannitol and 20 mM Hepes, pH 7.4). Hypotonic buffers were
prepared by adjusting the concentration of mannitol. Radio-
isotope efflux was determined by replacing the medium at 1–2 min
intervals, quantified by b- or c-radiation counting and expressed
as fractional efflux per min, as described previously [33].
Luciferin/luciferase assay
Cells were seeded at a concentration of 10%}cm# and incubated
for 4 h under a humidified atmosphere of 95% O
#
}5% CO
#
at
37 °C. Thereafter, cells were washed four times with isotonic
buffer (80 mM NaCl, 4.7 mM KCl, 1.3 mM CaCl
#
, 1 mM MgCl
#
,
10 mM glucose, 95 mM mannitol and 20 mM Hepes, pH 7.4).
ATP release was measured in real time immediately after adding
isotonic or hypotonic buffer containing the luciferin}luciferase
reagent using a Topcount.NXT luminometer (Packard, Meriden,
CT, U.S.A.). Values are expressed as accumulation of extra-
cellular ATP in time and corrected for the consumption of ATP
by the luciferase reaction. Hypotonic buffers were prepared by
adjusting the concentration of mannitol, and osmolality was
assessed using a cryoscopic osmometer (Osmomat 030; Salm &
Kipp B. V., Breukelen, The Netherlands).
Measurement of whole cell Cl− currents
Cells were bathed in a solution containing 110 mM CsCl, 5 mM
MgSO
%
, 3.5 mM sodium gluconate, 12 mM Hepes, 8 mM Tris
and 100 mM mannitol, pH 7.4. The intracellular pipette solution
contained 110 mM CsCl, 2 mM MgSO
%
, 25 mM Hepes, 1 mM
EGTA, 1 mM Na
#
ATP and 50 mM mannitol, pH 7.4. Patch
pipetteswere pulled from borosilicate glass (Clark Electromedical
Instruments, Pangbourne, Berks., U.K.) and had a resistance of
2–3 MX. To monitor the time course of current activation,
alternating step pulses (100-ms duration) from 0 to ‡100 mV
were applied every 30 s. Voltage dependence of whole-cell current
was monitored by applying step pulses (2-s duration, 7-s interval)
from fi100 mV to ›100 mV with 25-mV increments. For
command pulse control, data acquisition and analysis, pCLAMP
6 software (Axon Instruments, Foster City, CA, U.S.A.) was
used. All data were sampled at 5 kHz after being low-pass filtered
at 500 Hz with a Bessel filter (Axon Instruments).
Erk-1/2 activity assay
After stimulation, cells were washed once with ice-cold PBS and
1 ml of lysis buffer was added (1% Triton X-100, 150 mM NaCl,
10 mM Tris}HCl, 1 mM EDTA, 1 mM EGTA, 0.5% Nonidet
P-40, 0.2 mM Na
$
VO
%
, 0.2 mM PMSF, 1% aprotinin and
50 lg}ml leupeptin, pH 7.4). After 10 min (0 °C), lysates were
collected, cleared by centrifugation and the supernatants
were incubated with polyclonal anti-Erk antibodies (recognizing
both Erk-2 and, to a lesser extent, Erk-1) for 1 h. Thereafter,
Protein A–Sepharose was added and the mixture was incubated
for a further hour. The immunoprecipitates were washed three
times with lysis buffer and three times with kinase buffer (10 mM
Tris}HCl, 150 mM NaCl, 10 mM MgCl
#
and 0.5 mM dithio-
threitol, pH 7.4) and Erk-1}2 activity was determined by in
itro phosphorylation of myelin basic protein (MBP). Phos-
phorylation was carried out in 40 ll of kinase buffer supple-
mented with 0.5 mg}ml MBP, 25 lM ATP and 5 lCi of
[c-$#P]ATP (30 min, 37 °C). After termination of the reactions by
rapid centrifugation, boiling SDS sample buffer was added to the
supernatants. The samples were boiled for 5 min and subjected
to SDS}PAGE. Radioactivity of MBP was quantified by a
phospho-imaging system (Molecular Imaging System GS-363;
Bio-Rad, Hercules, CA, U.S.A.).
RESULTS
Osmotic cell swelling stimulates ATP release
The release of ATP from hypotonicity-provoked intestine 407
cells was monitored continuously using a luciferin}luciferase
bioluminescence assay. As shown in Figure 1, a shift from
isotonic to hypotonic medium caused a rapid increase in extra-
cellular ATP. The ATP release was stimulus-dependent and
continued for at least 15 min; only after mild hypo-osmotic
stimulation (a 20fi30% reduction in tonicity) was a tendency to
level off observed. Notably, the regulatory volume decrease
response under these conditions is completed within approx.
2–3 min [2]. Under all conditions tested, no detectable increase in
luminescence was observed in the presence of the nucleotide
hydrolase apyrase (results not shown).
Pre-treatment of the cells with 1,2-bis-(2-aminophenoxy)-
ethane-N,N,N«,N«-tetra-acetic acid acetoxymethyl ester (BAPTA-
AM) or cytochalasin B significantly inhibited the hypotonicity-
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Figure 1 ATP release in response to hypo-osmotic cell swelling
ATP release from intestine 407 cells was measured in real time using the luciferin/luciferase
assay immediately after addition of isotonic or hypotonic buffer. Data are expressed as
means‡S.E.M. (n fl 5). The amount of ATP present at timefl 0 [immediately after adding
isotonic (iso) or hypotonic (20fi50% hypo) buffer containing luciferin/luciferase reagent] was
taken as a baseline and was not significantly different between the experiments and the buffers
used (9.5‡0.1 pmol/106 cells).
induced ATP release (Table 1). In contrast, the hypotonicity-pro-
voked conductive "#&I− efflux was unaffected by BAPTA-AM
loading and was strongly potentiated by pre-treatment with
cytochalasin B after submaximal stimulation (20% hypotonicity ;
Table 1). Cytochalasin B, however, did not affect the response to
a saturating stimulus (30–50% ; Table 1). These results, together
with a clear difference in the time course of activation}
inactivationofosmo-sensitiveATPrelease andanion efflux (peaks
within 1–2 min), suggest that ATP leaves the cell through a
pathway separate from the volume-sensitive anion channels.
Notably, no significant differences were observed in either lactate
dehydrogenase leakage or MTT conversion within 15 min of
osmotic stimulation (50% tonicity ; results not shown), in-
dicating, together with our findings that the release of ATP is
regulated by intracellular calcium and requires an intact cyto-
Table 1 Effect of BAPTA-AM and cytochalasin B treatment on ATP release and hypotonicity-induced anion efflux
ATP release and fractional 125I− efflux were quantified from control, BAPTA-AM-loaded (25 lM, 1 h) and cytochalasin B-pre-treated (50 lM, 30 min) intestine 407 cells. ATP accumulation was
determined after 15 min of incubation with isotonic or hypotonic medium. Activation of the anion conductance was determined by measuring the initial increase in fractional 125I− efflux at 90 s
after changing the medium for an isotonic or hypotonic medium. Data are expressed as means‡S.E.M. (n fl 3).
ATP accumulation (pmol/106 cells) Increase in fractional iodide efflux (%/min)
Experimental condition Isotonic 50% Hypotonic Isotonic 20% Hypotonic 50% Hypotonic
Control 4.3‡1.0 23.1‡4.1 fi0.7‡0.4 6.7‡1.7 32.4‡0.3
BAPTA-AM 1.9‡0.8 7.6‡2.3* fi0.2‡0.1 6.4‡0.5 31.1‡1.4
Cytochalasin B 0.3‡0.2* 8.0‡2.0* 1.4‡1.5 15.3‡1.1* 29.5‡1.9
* Significant difference from the control (P ! 0.05, Student’s t test).
skeleton, that the increase in extracellular ATP is due to enhanced
release from viable cells and not due to cell lysis.
Effects of extracellular nucleotides on osmo-sensitive anion efflux
The effects of extracellular ATP on anion transport were in-
vestigated by quantifying radioisotope efflux from "#&I−-loaded
monolayers of intestine 407 cells. Whereas extracellular ATP
(0.1 lM–10 mM) was unable to evoke a "#&I− efflux by itself
(Figure 2A), micromolar concentrations (10–100 lM) greatly
potentiated the anion efflux in response to a submaximal (20%
reduction in tonicity) osmotic stimulus (Figure 2A). Potentiation
of the swelling-induced anion efflux by ATP could have been due
to an increase in iodide permeability (genuine potentiation) or to
an increase in driving force (stimulation of Ca#+-activated K+
channels). Two different experiments were performed to in-
vestigate whether the isotope efflux is mainly a function of the
number of activated anion channels or is affected also by the
membrane potential. (i) Potentiation of the efflux by ATP was
not observed after maximal (30% reduction in tonicity) hypo-
tonic stimulation: peak "#&I− efflux, 38.7‡0.8%}min in the
absence and 39.8‡1.5%}min in the presence of 100 lM ATP
(mean‡S.E.M., nfl 3). Under these conditions the )’Rb+ efflux
(indicative of K+ permeability) was increased approx. 2-fold:
peak )’Rb+ efflux, 3.5‡0.2%}min in the absence and 5.9‡
0.4%}min in the presence of 100 lM ATP (nfl 3). (ii) Treating
the cells with the K+ ionophore valinomycin (10 lM) did not
further increase the "#&I− efflux in response to a 30% hypotonic
medium: peak "#&I− efflux was 32.2‡2.8%}min in the control
versus 31.7‡1.2%}min in the presence of valinomycin (nfl 3).
Furthermore, as published previously [34], brief treatment of the
cells with PMA completely inhibited the hypotonicity-induced
)’Rb+ efflux, but did not affect the osmo-sensitive "#&I− efflux.
These results show that the isotope efflux is virtually independent
of the membrane potential. Taken together, micromolar con-
centrations of extracellular ATP potentiate the "#&I− efflux
through an increase in membrane permeability rather than by
increasing the driving force for anion efflux by enhancing the K+
conductance.
Increasing concentrations of ATP (& 1 mM) not only reduced
the potentiation of the hypotonicity-provoked "#&I− efflux, but
eventually abolished the isotope efflux almost completely (Figure
2A). Similar results (not shown) were obtained when Mg-ATP
was used, indicating that the inhibition observed was not due to
a reduction in extracellular [Mg#+].
Pre-treatment of the cells with BAPTA-AM (25 lM, 1 h) did
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Figure 2 Effects of ATP on radioisotope release from 125I−- or 45Ca2+-loaded cells
(A) Dose-dependency of the effects of ATP on the fractional 125I− efflux from control (D) and osmotically stimulated (20% hypotonicity, E) cultures. (B) Dose-dependency of the ATP-induced
fractional 45Ca2+ efflux from radioisotope-loaded cells under isotonic conditions. Data are expressed as means‡S.E.M. (n fl 3).
Figure 3 Calcium dependence of ATP-mediated potentiation of the osmo-
sensitive anion efflux
Time course of the osmo-shock-induced (20% hypotonicity) fractional 125I− efflux from control
(D, *) or BAPTA-AM-loaded (25 lM, 1 h ; E, +) cultures in the presence (D, E) or
absence (*, +) of ATP (50 lM). ATP or vehicle was added from 3 min onwards ; the arrow
indicates the shift to hypo-osmotic medium. Data are expressed as means‡S.E.M. (n fl 3).
not affect the anion-efflux response to hypo-osmotic stimulation
but completely abolished the potentiation of the efflux by
micromolar concentrations of ATP (Figure 3). These results
suggest that the potentiation of the hypotonicity-induced anion
efflux by extracellular ATP is due to an increase in intracellular
Ca#+. Indeed, addition of ATP to the medium was found to result
in an increased cellular mobilization of Ca#+, as quantified by
%&Ca#+ efflux from isotope-loaded cells (Figure 2B). The ATP-
mediated Ca#+ release starts, like the potentiation of the hypo-
Table 2 Order of potency of nucleotides in potentiating the hypotonicity-
induced 125I− efflux in intestine 407 cells
Increase in fractional 125I− efflux in response to a 20% hypotonic shock was determined in the
absence or presence of equimolar concentrations (10 lM) of extracellular nucleotides. Data are
expressed as percentages of the control and are given as means‡S.E.M. (with n values in
parentheses). ATP[S], adenosine 5«-[c-thio]-triphosphate ; GTP[S], guanosine 5«-[c-thio]-
triphosphate.
Experimental condition Increase in fractional 125I− efflux (%)
Control 100‡6 (8)
ATP 194‡8* (8)
ATP[S] 186‡7* (5)
UTP 185‡17* (3)
ADP 153‡8* (3)
GDP 140‡12 (3)
GTP[S] 138‡9* (3)
AMP 134‡14 (3)
GTP 122‡2* (3)
Adenosine 107‡3 (3)
cAMP 91‡15 (3)
* Significant difference from the control (P ! 0.05, Student’s t test).
tonicity-provoked anion efflux, at micromolar conditions and
saturates at approx. 0.1–1 mM, but, in contrast with ATP effects
on chloride-channel activation, no inhibition of the Ca#+ efflux
was observed at millimolar concentrations (Figure 2). Taken
together, these results suggest that different mechanisms underlie
the potentiation and inactivation of the anion conductance.
Extracellular ATP is known to induce Ca#+ mobilization by
activation of G-protein-coupled purinoceptors, which are divided
into subtypes on the basis of differing agonist-affinity series
(reviewed in [35]). To investigate the receptor involved in the
ATP effect on the osmo-sensitive anion efflux, the relative
potencies of adenine- and uridine-containing nucleotides were
determined. As shown in Table 2, this affinity profile (UTPfl
ATPflATP[S]"ADPflAMP; cAMP and adenosine ineffec-
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Figure 4 Volume-sensitive chloride currents in intestine 407 cells
Whole-cell Cl− currents in control (isotonic ; A) and hypo-osmotic stimulated (B) cells in
response to step pulses from fi100 to ›100 mV (in 25-mV increments). (C) Inhibition of the
cell-swelling-induced Cl− current by extracellular ATP (5 mM). Traces are representative of 20
(A, B) and 6 (C) experiments.
tive) closely resembles the agonist specificity of the P2Y
#
(flP2U) type of receptor as characterized by Lustig et al. [36].
Effect of purinoceptor antagonists and the ATP hydrolase apyrase
on osmo-sensitive Cl− currents
Although extracellular ATP alone was not sufficient to activate
an anion current in Intestine 407 cells, hypo-osmotically released
ATP may play an important role in the feed-forward regulation
of compensatory Cl− channels. To verify this possibility, both the
hypotonicity-provoked whole-cell Cl− currents as well as the "#&I−
efflux in intact cells were measured in the absence and presence
of apyrase (3 units}ml).
When exposed to a hypo-osmotic medium, Intestine 407 cells
respond by developing a large, Cl−-selective, outwardly rectifying
current (Figures 4A and 4B). The anion current displayed a slow
activation after strong hyperpolarizing pulses and a marked
voltage-dependent inactivation at depolarizing holding poten-
tials. Addition of millimolar concentrations of extracellular ATP
blocks the hypotonicity-induced anion efflux in a voltage-de-
pendent manner (Figure 4C). Similar currents have been reported
by others for this cell line and for many other cell systems (for
review, see [16,37]). Addition of apyrase to the bathing solution
did not prevent the activation of the osmo-sensitive current
(Figure 5A), nor did it affect the magnitude of the cell-swelling-
induced "#&I− efflux from intact cells (Table 3). Similar results
were obtained when a hexokinase}glucose system was used to
trap released ATP (results not shown). Furthermore, addition of
Figure 5 Time course of activation and inhibition of osmo-sensitive
chloride currents
(A) Hypotonicity-provoked whole-cell Cl− currents at fi100 and ›100 mV in the presence
of apyrase (3 units/ml) and after subsequent addition of suramin (100 lM). (B) Magnitude of the
whole-cell Cl− currents after addition of ATP (50 lM), a shift to a hypotonic medium (30%
hypotonicity) and subsequent addition of 5 mM ATP. Traces are representative of six
experiments.
micromolar concentrations of ATP to the bathing solution did
not induce an increase in Cl− current under isotonic conditions
(Figure 5B). Taken together, these findings again indicate that,
under our conditions, extracellularly released ATP triggered by
osmotic cell swelling is not involved in the activation or poten-
tiation of volume-sensitive Cl− currents.
Paradoxically, after treatment of the cells with the purinoceptor
antagonists suramin and reactive blue, a strong inhibition of the
hypotonicity-induced anion efflux was observed (Table 3), sug-
gesting a role for purinoceptors in the activation of the chloride
efflux. Furthermore, addition of suramin (Figure 5A) or reactive
blue (results not shown) to the bathing solution effectively
decreased swelling-induced whole-cell Cl− currents. Inhibition by
both antagonists, like the inhibition by millimolar concentrations
of extracellular ATP (Figure 5B), was voltage-dependent (out-
ward currents were inhibited much more prominently than
inward currents). Combined with the observation that addition
of apyrase to the bathing solution had no effect on the de-
velopment of hypotonicity-induced Cl− currents (Figure 5A and
Table 3), these results indicate that the inhibition of hypotonicity-
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Table 3 Effect of ATP hydrolase apyrase and purinoceptor antagonists on
hypotonicity-induced 125I− efflux
Fractional 125I− efflux was determined in response to 20 and 30% hypotonic shocks in the
presence or absence (control) of 3 units/ml apyrase, 100 lM suramin or 100 lM reactive blue.
Data are expressed as percentages of control (means‡S.E.M., n fl 3).
Hypotonicity
Experimental condition 20% 30%
Control 100‡5 100‡5
Apyrase 93‡8 108‡5
Suramin 38‡4* 55‡6*
Reactive blue 34‡4* 75‡2*
* Significant difference from the control (P ! 0.05, Student’s t test).
Figure 6 Dose-dependency of ATP-induced Erk-1/2 activation
Cells were exposed for 5 min to isotonic medium containing different concentrations of ATP or
to a 30% hypotonic medium in the presence of 200 lM Na3VO4. After lysis of the cells, Erk-
1/2 was immunoprecipitated and enzyme activity was determined using MBP as a substrate
(as described in the Materials and methods section). Data are expressed as percentages of the
control (means‡S.E.M., n fl 3).
induced Cl− channels by suramin and reactive blue is unrelated
to their action as purinoceptor blockers.
Autocrinic release of ATP mediates swelling-induced Erk-1/2
activation
Recently, we demonstrated that hypo-osmotic stimulation of
intestine 407 cells transiently activates Erk-1}2 through the
Ras}Raf signalling pathway [14]. Because ATP has been reported
to activate MAP kinases in some other cell types [21–27], we
investigated the possible autocrinic}paracrinic involvement of
osmotically released ATP. It was found that extracellular ATP
under isotonic conditions acts as a potent activator of Erk-1}2 in
intestine 407 cells (Figure 6). For comparison, the effect of a
30% hypotonic shock on Erk-1}2 activation is also shown in
Figure 6. Stimulation of Erk-1}2 started at concentrations of
0.1–0.5 lM, indicating that the threshold for MAP kinase
activation by ATP is two orders of magnitude lower than its
threshold for the activation of Ca#+ efflux and for the potentiation
of osmo-sensitive anion efflux (see Figure 2). As shown in Figure
Figure 7 Extracellularly released ATP activates Erk-1/2
Erk-1/2 was immunoprecipitated and enzyme activity was determined using MBP as a
substrate. (A) Following a 5-min incubation with vehicle (fi) or with 3 units/ml apyrase (›),
cells were exposed for another 5 min to isotonic medium, 30% hypotonic medium, 100 lM ATP
or 100 lM UTP in the presence of Na3VO4 (200 lM). Shown is an autoradiograph of
32P-
labelled MBP separated by SDS/PAGE ; results are representative of three independent
experiments. (B) Following a 15-min incubation with vehicle (fi), reactive blue (100 lM) or
suramin (100 lM), cells were exposed for 5 min to isotonic (open bars) or 30% hypotonic
(hatched bars) medium. Data are expressed as percentages of the untreated control
(means‡S.E.M., n fl 3). An asterisk indicates a significant difference from the control (P !
0.05, Student’s t test).
7(A), treatment of the cells with apyrase (3 units}ml) not only
abolished the ATP}UTP-induced Erk-1}2 activation, but also
almost completely inhibited its activation by hypo-osmotic stress.
Moreover, pre-treatment of the cells with suramin (100 lM,
15 min) or reactive blue (100 lM, 15 min) significantly inhibited
the hypotonicity-induced Erk-1}2 activation (Figure 7B). These
results indicate that extracellular ATP, acting as an autocrinic
factor, is largely responsible for the hypotonicity-induced Erk-
1}2 activation and, because UTP was equipotent, mediates its
effects through P2Y
#
-receptor signalling.
DISCUSSION
Hypo-osmotic cell swelling induces a rapid increase in the K+-
and Cl−-selective conductances and the concomitant activation
of multiple signalling pathways. In intestine 407 cells, some
components of these pathways, like p21rho and PtdIns 3-kinase,
were found to be indispensable for a proper activation of the
volume-sensitive Cl− channels, whereas others, like the members
of the MAP kinase superfamily, are apparently not involved
[2,7,13,14]. Recent studies in HTC hepatoma cells suggest that
both the hypotonicity-induced Cl−-current activation and the
subsequent cell-volume recovery completely depend on a cell-
swelling-induced conductive ATP efflux [18,30]. Similar to HTC
hepatoma cells, intestine 407 cells respond to a hypo-osmotic
shock with a release of ATP into the medium. The ATP release
was stimulus-dependent and relatively sustained, lasting for at
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least 10–15 min. Notably, the regulatory volume decrease re-
sponse under these conditions is completed in approx. 2–3 min
[2]. Both the ATP-binding-cassette proteins CFTR (cystic fibrosis
transmembrane-conductance regulator) and P-glycoprotein have
been proposed to function as ATP-release channels or to regulate
an as-yet-unidentified associated ionic channel [17,30,38–40].
Other investigators however, have failed to establish a link
between CFTR}P-glycoprotein and ATP release [19,41–43]. In
intestine 407 cells, CFTR Cl− channels are not expressed [2] and,
in the subclone we use, P-glycoprotein expression is not detectable
by RNAse protection assay (results not shown), arguing against
a role for these ATP-binding-cassette transporters in ATP release.
This notion is supported by the findings of Tominaga et al. [44],
using a differ(inent, P-glycoprotein-expressing, subclone of intes-
tine 407 cells. They found that inhibition of P-glycoprotein
expression or function by treatment with anti-sense oligo-
nucleotides or verapamil did not affect the osmo-sensitive Cl−
current [44]. Hypotonicity-induced ATP release was inhibited by
BAPTA-AM and cytochalasin B whereas cell-swelling-induced
anion efflux was strongly potentiated by cytochalasin B treatment
and unaffected by Ca#+ chelation (see Table 1). These findings,
together with the difference in kinetics between hypotonicity-
induced ATP release and anion efflux, argue against conductive
ATP efflux through volume-regulated Cl− channels. In contrast,
although rather speculative, the dependency of the ATP release
on intracellular Ca#+ and an intact cytoskeleton suggests the
involvement of an exocytotic process.
Based upon the inhibitory action of apyrase and of the
purinoceptor antagonists suramin and reactive blue, Wang et al.
[18] concluded that, in HTC rat hepatoma cells, extracellularly
released ATP, through a P2-type receptor other that P2Y
#
, was
obligatory for the activation of volume-sensitive anion channels.
The results of our study, however, demonstrate clearly that
extracellularly released ATP is not involved in the activation of
osmo-regulated Cl− channels in intestine 407 cells, as evidenced
by the inability of applied ATP to evoke an anion conductance
under isotonic conditions and by the insensitivity of the hypo-
tonicity-provoked anion efflux to apyrase. Instead of a direct
activation of Cl− conductances, micromolar concentrations of
ATP were found to greatly potentiate the ionic response to a
submaximal hypotonic stimulus, most likely through P2Y
#
-
receptor activation (as evidenced by the order of potency of
different nucleotides) and subsequent Ca#+ mobilization (as
evidenced by %&Ca#+-efflux studies and potentiation studies in
BAPTA-AM-loaded cultures).
Potentiation of the ionic responses to osmotic cell swelling is
not unprecedented. Indeed, in intestine 407 cells, Ca#+-mobilizing
hormones as well as the phosphotyrosine phosphatase inhibitor
(peroxo)vanadate and cytochalasin B were found to increase the
anion efflux [2,7,34]. These data confirm the previous notion that
intestine 407 cells do not express Ca#+-activated anion channels
[2,34], implying that ATP}Ca#+ potentiation of anion efflux is a
regulatory property of the volume-sensitive Cl− channels.
Importantly, the inhibition of volume-sensitive Cl− channels
by millimolar concentrations of ATP appeared to be independent
of P2Y
#
-receptor signalling because at those concentrations the
ATP activation of %&Ca#+ efflux was unaffected. Not only high
concentrations of extracellular ATP ( 5 mM), but also the
purinoceptor antagonists suramin and reactive blue, were found
to inhibit both the volume-sensitive anion efflux and the hypo-
tonicity-provoked whole-cell Cl− current significantly. These
results are in line with the recent findings of Galietta et al. [45],
who reported an inhibition of swelling-induced taurine efflux and
Cl− currents by purinoceptor antagonists in 9HTE
!
− cells. The
inhibition by ATP, suramin and reactive blue (i.e. by both
purinoceptor agonist and antagonists) was voltage-dependent
and therefore suggests a direct interaction with the extracellular
domains of the channel protein. This property renders these
antagonists less suitable for investigating the involvement of
purinoceptors in Cl−-channel activation, but makes it tempting
to speculate that volume-regulated anion channels share homol-
ogous nucleotide-binding domains with the P2Y
#
receptors.
Notably, the ATP concentrations reached in the close proximity
of the cells in io are difficult to assess. As recently shown by
Beigi et al. [46], who used cell-surface-attached luciferase to
measure ATP release from platelets, the ATP concentration
measured by soluble luciferase in bulk extracellular fluids, as
done in our studies, may greatly underestimate the concentration
of ATP at the cell surface. Considering the micromolar rather
than millimolar concentrations of released ATP found at the cell
surface by Beigi et al. [46], the physiological role for cell-swelling-
induced ATP release is most plausibly potentiation of channel
activity (requiring micromolar levels of extracellular ATP) rather
than channel inhibition.
A general feature of cell signalling in response to hypotonic
stress is the activation of the extracellular signal-regulated protein
kinases Erk-1 and Erk-2 [2,8–14]. In this study, we demonstrate
that the activation of these MAP kinases is not a direct
consequence of osmotic cell swelling, but instead involves an
autocrinic}paracrinic loop with ATP as the first messenger. The
ability of exogenously added ATP to potentiate the osmo-
sensitive anion efflux is somewhat contradictory to the obser-
vations that released ATP is responsible for Erk-1}2 activation
but is apparently not involved in the regulation of "#&I− efflux or
Cl− current (e.g. no reduction in magnitude in the presence of
apyrase ; Table 3 and Figure 5A). We suggest that there are at
least two plausible explanations for this apparent discrepancy.
First, comparison of Figures 2(A) and 6 shows that the threshold
for Erk-1}2 activation by ATP is about two orders of magnitude
lower compared with ATP potentiation of the anion efflux or
activation of Ca#+ channels. Second, in contrast with the con-
ditions of the Erk-1}2 experiments, in the efflux assay, the
extracellular medium is replaced at 1 min intervals to assess the
release of radioisotope, thereby reducing unstirred layer dimen-
sions and preventing ATP from accumulating.
The finding that UTP is as effective as ATP suggests a second
role for the P2Y
#
receptor, a G-protein-coupled receptor, which
was also found to be responsible for the potentiation of the
swelling-induced anion efflux. In several cell systems, receptors
coupled to the G-protein subfamilies G
q/""
, G
i/!
, G
s
or G
"#/"$
were found to activate the Ras}Raf}Erk cascade (reviewed in
[47,48]). However, since the hypotonicity-provoked activatiof
Erk-1}2 was insensitive to pertussis toxin in intestine 407 cells
[14], involvement of G
i/!
is not likely. Notably, Erk-1}2 activation
was found to be more sensitive to extracellular ATP than the
Ca#+-mediated potentiation of hypotonicity-induced anion efflux
(submicromolar versus micromolar levels). The reason for this
difference is unknown, but may relate to the involvement of
multiple P2Y
#
-receptor subtypes, or to a different sensitivity of
the signalling pathways to submaximal receptor activation.
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